NAFLD incidence and remission: Only a matter of weight gain and weight loss?

Journal of Hepatology

Volumn 62, Issue 1, 2015, Pages 15-17

  Marchesini, Giulio ^a   Mazzotti, Arianna ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIVER ENZYME;

ALCOHOL CONSUMPTION; ANTIVIRAL THERAPY; DIETARY INTAKE; EDITORIAL; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INSULIN RESISTANCE; LIPOPROTEIN METABOLISM; LIVER TRANSPLANTATION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; OVERALL SURVIVAL; PHYSICAL ACTIVITY; PREVALENCE; PROTON NUCLEAR MAGNETIC RESONANCE; REMISSION; TERTIARY HEALTH CARE; WAIST CIRCUMFERENCE; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION; FEMALE; HEALTH SURVEY; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES;

FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; POPULATION SURVEILLANCE;

EID: 84918520655     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.10.023     Document Type: Editorial

References (20)

1. Y. Wang, M.A. Beydoun, L. Liang, B. Caballero, and S.K. Kumanyika Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic Obesity (Silver Spring) 16 2008 2323 2330
2. International Diabetes Federation. IDF Diabetes Atlas: Executive Summary. Available at: < https://wwwidforg/sites/default/files/EN-6E-Atlas-Exec-Sum-0pdf >; 2013.
3. M. Hamaguchi, T. Kojima, N. Takeda, T. Nakagawa, H. Taniguchi, and K. Fujii The metabolic syndrome as a predictor of non-Alcoholic fatty liver disease Ann Intern Med 143 2005 722 728
4. S. Bruno, P. Maisonneuve, P. Castellana, N. Rotmensz, S. Rossi, and M. Maggioni Incidence and risk factors for non-Alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial BMJ 330 2005 932 937
5. A. Suzuki, P. Angulo, J. Lymp, J. St Sauver, A. Muto, and T. Okada Chronological development of elevated aminotransferases in a non-Alcoholic population Hepatology 41 2005 64 71
6. G. Bedogni, L. Miglioli, F. Masutti, A. Castiglione, L.S. Croce, and C. Tiribelli Incidence and natural course of fatty liver in the general population: the Dionysos study Hepatology 46 2007 1387 1391
7. A. Tsuneto, A. Hida, N. Sera, M. Imaizumi, S. Ichimaru, and E. Nakashima Fatty liver incidence and predictive variables Hypertens Res 33 2010 638 643
8. S. Zelber-Sagi, R. Lotan, A. Shlomai, M. Webb, G. Harrari, and A. Buch Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up J Hepatol 56 2012 1145 1151
9. C. Xu, C. Yu, H. Ma, L. Xu, M. Miao, and Y. Li Prevalence and risk factors for the development of non-Alcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study Am J Gastroenterol 108 2013 1299 1304
10. K.C. Sung, S.H. Wild, and C.D. Byrne Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension J Hepatol 60 2014 1040 1045
11. V.W.-S. Wong, G.L.-H. Wong, D.K.-W. Yeung, T.K.-T. Lau, C.K.-M. Chan, and A.M.-L. Chim Incidence of non-Alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy J Hepatol 62 2015 182 189
12. J.D. Browning, J. Davis, M.H. Saboorian, and S.C. Burgess A low-carbohydrate diet rapidly and dramatically reduces intrahepatic triglyceride content Hepatology 44 2006 487 488
13. K.F. Petersen, S. Dufour, D. Befroy, M. Lehrke, R.E. Hendler, and G.I. Shulman Reversal of non-Alcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes Diabetes 54 2005 603 608
14. A. Suzuki, K. Lindor, J. St Sauver, J. Lymp, F. Mendes, and A. Muto Effect of changes on body weight and lifestyle in non-Alcoholic fatty liver disease J Hepatol 43 2005 1060 1066
15. Z.M. Younossi, M. Stepanova, F. Negro, S. Hallaji, Y. Younossi, and B. Lam Non-Alcoholic fatty liver disease in lean individuals in the United States Medicine (Baltimore) 91 2012 319 327
16. B. Vos, C. Moreno, N. Nagy, F. Fery, M. Cnop, and P. Vereerstraeten Lean non-Alcoholic fatty liver disease (Lean-NAFLD): a major cause of cryptogenic liver disease Acta Gastroenterol Belg 74 2011 389 394
17. E. Bugianesi, A. Gastaldelli, E. Vanni, R. Gambino, M. Cassader, and S. Baldi Insulin resistance in non-diabetic patients with non-Alcoholic fatty liver disease: sites and mechanisms Diabetologia 48 2005 634 642
18. A.C. Dela Cruz, E. Bugianesi, J. George, C.P. Day, H. Liaquat, and P. Charatcharoenwitthaya Characteristics and long-term prognosis of lean patients with non-Alcoholic fatty liver disease Gastroenterology 146 2014 S-909
19. S. Romeo, J. Kozlitina, C. Xing, A. Pertsemlidis, D. Cox, and L.A. Pennacchio Genetic variation in PNPLA3 confers susceptibility to non-Alcoholic fatty liver disease Nat Genet 40 2008 1461 1465
20. L. Montesi, C. Caselli, E. Centis, C. Nuccitelli, S. Moscatiello, and A. Suppini Physical activity support or weight loss counseling for non-Alcoholic fatty liver disease? World J Gastroenterol 20 2014 10128 10136